Fundamentals · JNJ
Peer Comparison for JNJ
AI-generated plain-English read of peer comparison for JNJ. Updated daily.
Rich premium vs peers, in-line growth
moderateJNJ is priced at 1.53x the sector median with middling fundamentals: investors are paying up without a clear fundamental justification.
What to do
- If you HOLD this stock
- Hold a core position pending a clearer fundamental signal; the peer picture is mixed and doesn't strongly argue for adding or trimming.
- If you're EVALUATING this stock
- Mixed peer-relative picture. Build a half-position if the primary thesis is strong; wait for one more quarter of data before full sizing.
- If you trade OPTIONS
- Peer comparison alone doesn't point strongly in one direction. Let other signals (momentum, sentiment) determine directional bias; use spreads to limit premium outlay.
8 peers and 2 valuation metric(s): sufficient but not robust. Treat directional buckets as indicative rather than definitive.
Technical details
Technical analysis
- Relative multiple (target / peer median)
- 1.53x
- Target P/E
- 29.5x
- Peer median P/E
- 19.3x
- Relative valuation
- Rich Premium
- Growth ranking
- In Line Growth
- Profitability rank
- In Line Prof
- Outlier flag
- Neutral
- Sector
- Pharmaceuticals
- Peer count
- 8
Key levels
| Level | Value |
|---|---|
| target pe | 29.458 |
| peer median pe | 19.274 |
| valuation ratio | 1.528 |
| n peers | 8 |
Caveats
- Peer comparisons are a single-snapshot read. Multi-quarter trends often matter more than current-quarter relative levels.